A 26-week Tolerability Study of Ciclesonide Nasal Aerosol in Patients with Perennial Allergic Rhinitis

E. Berger, William; Mohar, Dale; LaForce, Craig; Raphael, Gordon; Y. Desai, Shailesh; Huang, Holly; Hinkle, Joseph

doi:10.2500/ajra.2012.26.3773

Public

A 26-week Tolerability Study of Ciclesonide Nasal Aerosol in Patients with Perennial Allergic Rhinitis

Published in American Journal of Rhinology and Allergy • Jul 1, 2012

Authors:

William E. Berger

Dale Mohar

Craig LaForce

Abstract

BACKGROUND: A new, hydrofluoroalkane nasal aerosol solution formulation of ciclesonide (CIC-HFA) delivered via a metered dose inhaler is currently in clinical development for treatment of allergic rhinitis. OBJECTIVE: To study tolerability and quality of life following administration of CIC-HFA 74- ...

Subject

Medicine

Tolerability

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!